It is not FDA-approved for any use, it has never been FDA-approved, and PlexusDx does not sell, distribute, or prescribe retatrutide or any other investigational peptide in this category
GLP-1 side effects and treatment can vary from person to person
Your GP can refer you to an NHS weight management service, which may then prescribe the medication if you meet the criteria and have previously tried lifestyle interventions
Body-Composition Effects of Tirzepatide (SURMOUNT-1 Study) Look M, Dunn JP, Kushner RF, et al
The glucagon receptor activation increases energy expenditure, meaning some of the weight loss comes from increased caloric burn rather than purely from caloric restriction
Measurable weight loss typically begins by weeks 4 to 6, with 5 to 10 percent body weight loss common by months 3 to 4